Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
NHC
STRONG BUYFLAGNational HealthCare Corporation · Healthcare · United States · $3.5B · Avg Vol: $33M/d
National HealthCare has Q76 M70 but value at V43 is below the calibrated floor, and the insider picture is net selling (0.11% sold against 0.01% bought). A good operator at a full price with management trimming.
COMPANY DESCRIPTION
National HealthCare Corporation operates an integrated network of skilled nursing facilities, assisted living, independent living, and homecare agencies across the southeastern United States. The company's strength lies in its comprehensive continuum of care services, strong regional presence, and long-standing reputation for quality patient care. This diversified approach to senior care allows for multiple revenue streams and caters to varying levels of patient needs within its core markets.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1.1B | 1.1B | 1.3B | 1.5B | 12.2% | 1.5B |
| EPS | 1.46 | 4.36 | 6.62 | 7.76 | 74.5% | 7.87 |
| Shares | 15.4M | 15.4M | 15.5M | 15.5M | +1.2% | 15.6M |
| Debt | 125.9M | 93.4M | 214.8M | 87.1M | -11.6% | 39.3M |
| Equity | 874.3M | 908.8M | 980.2M | 1.1B | 6.9% | — |
| Op CF | 8.7M | 111.2M | 107.3M | 185.1M | 176.6% | 208.4M |
| Inv CF | -6.0M | -17.6M | -236.7M | -33.9M | — | — |
| Fin CF | -47.6M | -42.5M | 100.3M | -136.0M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NHC are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| NHC | National HealthCare Corporation(you) | $3.5B | 90 | STRONG BUY |
| GRDN | Guardian Pharmacy Services, Inc. | $2.6B | 91 | STRONG BUY |
| CON | Concentra Group Holdings Parent, Inc. | $4.0B | 82 | STRONG BUY |
| ADUS | Addus HomeCare Corporation | $2.1B | 93 | STRONG BUY |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.1B | 92 | STRONG BUY |
| ASTH | Astrana Health, Inc. | $2.0B | 86 | STRONG BUY |
| CHE | Chemed Corporation | $6.8B | 87 | STRONG BUY |
| LFST | LifeStance Health Group, Inc. | $4.2B | 76 | BUY |
| MD | Pediatrix Medical Group, Inc. | $2.2B | 97 | STRONG BUY |
| HCSG | Healthcare Services Group, Inc. | $1.6B | 91 | STRONG BUY |
Peer medians: ROE -21.2% · P/E 27.7x · Gross margin 50.0%